載入...
Antibody-Drug Conjugates in Bladder Cancer
Urothelial carcinoma (UC) is characterized by expression of a plethora of cell surface antigens, thus offering opportunities for specific therapeutic targeting with use of antibody-drug conjugates (ADCs). ADCs are structured from two major constituents, a monoclonal antibody (mAb) against a specific...
Na minha lista:
| 發表在: | Bladder Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
IOS Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6087439/ https://ncbi.nlm.nih.gov/pubmed/30112436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-180169 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|